CGAS and neoplasm: Based on scRNA-seq data suggesting a strong type I IFN response in GSDMD-deficient macrophages, in combination with the finding that global cGAS deletion prevented the aforementioned effects, the authors proposed cGAS-dependent type I IFN response in macrophages to be responsible for the observed anti-tumor immune response (203).